Rasbach Kyle
SEC insider (Form 3/4/5 filer). CIK 0002050086. Chief Financial Officer at Lexeo Therapeutics, Inc. (LXEO). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 17, 2025. Located in NEW YORK, NY.
Companies Rasbach Kyle has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Officer, Chief Financial Officer
Rasbach Kyle
CIK: 0002050086
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LXEO
Lexeo Therapeutics, Inc.
Officer